{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:45:01Z","timestamp":1789728301123,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019637","name":"Horizon Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ymgmr.2022.100906","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T15:26:55Z","timestamp":1659194815000},"page":"100906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["Variable disease manifestations and metabolic management within a single family affected by ornithine transcarbamylase deficiency"],"prefix":"10.1016","volume":"33","author":[{"given":"Joshua","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Hitchins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Vucko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Havens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Arduini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2022.100906_bb0005","series-title":"GeneReviews\u00ae [Internet]","article-title":"Urea cycle disorders overview","author":"Mew","year":"2003"},{"key":"10.1016\/j.ymgmr.2022.100906_bb0010","series-title":"GeneReviews\u00ae [Internet]","article-title":"Ornithine transcarbamylase deficiency","author":"Lichter-Konecki","year":"2013"},{"key":"10.1016\/j.ymgmr.2022.100906_bb0015","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1007\/PL00014402","article-title":"The molecular basis of ornithine transcarbamylase deficiency","volume":"159","author":"Tuchman","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0020","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41436-020-0779-4","article-title":"X-linked diseases: susceptible females","volume":"22","author":"Migeon","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0025","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/21678707.2017.1405807","article-title":"Glycerol phenylbutyrate for the maintenance treatment of patients with deficiencies in enzymes of the urea cycle","volume":"5","author":"Longo","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymgmr.2022.100906_bb0030","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"H\u00e4berle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0035","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1651-2227.2008.00952.x","article-title":"Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes","volume":"97","author":"Summar","year":"2008","journal-title":"Acta Paediatr Int. J. Paediatr."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ccc.2005.05.007","article-title":"Urea cycle disorders: clinical presentation outside the newborn period","volume":"21","author":"Smith","year":"2005","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41431-018-0291-3","article-title":"Skewed X-inactivation is common in the general female population","volume":"27","author":"Shvetsova","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0050","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/jimd.12404","article-title":"OTC deficiency in females: phenotype-genotype correlation based on a 130-family cohort","volume":"44","author":"Gobin-Limballe","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0055","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s10545-007-0718-4","article-title":"Nutritional management of patients with urea cycle disorders","volume":"30","author":"Singh","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0060","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ccc.2005.08.003","article-title":"Nutritional management of urea cycle disorders","volume":"21","author":"Singh","year":"2005","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajmg.a.30414","article-title":"Severe, neonatal-onset OTC deficiency in twin sisters with a de novo balanced reciprocal translocation t(X;5)(p21.1;q11)","volume":"132A","author":"Zenker","year":"2005","journal-title":"Am. J. Med. Genet. Part A."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ana.10794","article-title":"Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency","volume":"55","author":"Gyato","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0075","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ymgme.2010.01.017","article-title":"Brain imaging in urea cycle disorders","volume":"100","author":"Gropman","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01799346","article-title":"Identification of new mutations in the ornithine transcarbamylase (OTC) gene in Korean families","volume":"19","author":"Yoo","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0085","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1203\/00006450-200012000-00023","article-title":"Expression of wild-type and mutant human ornithine transcarbamylase genes in chinese hamster ovary cells and lack of dominant negative effect of R141Q and R40H mutants","volume":"48","author":"Augustin","year":"2000","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-8628(19961218)66:3<311::AID-AJMG14>3.0.CO;2-P","article-title":"Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation","volume":"66","author":"Ahrens","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1023\/A:1005353407220","article-title":"The biochemical and molecular spectrum of ornithine transcarbamylase deficiency","volume":"21","author":"Tuchman","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0100","series-title":"J. Inherit. Metab. Dis","first-page":"448","article-title":"Vademecum metabolicum. Manual of metabolic paediatrics","volume":"23","author":"Pollitt","year":"2000"},{"key":"10.1016\/j.ymgmr.2022.100906_bb0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13023-016-0548-2","article-title":"Experiences of caregivers of children with inherited metabolic diseases: a qualitative study","volume":"11","author":"Siddiq","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0110","author":"U.S.G.A. Office"},{"key":"10.1016\/j.ymgmr.2022.100906_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-01943-w","article-title":"Navigating the U.S. health insurance landscape for children with rare diseases: a qualitative study of parents\u2019 experiences","volume":"16","author":"Pasquini","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ymgmr.2016.07.003","article-title":"Barriers to drug adherence in the treatment of urea cycle disorders: assessment of patient, caregiver and provider perspectives","volume":"8","author":"Shchelochkov","year":"2016","journal-title":"Mol. Genet. Metab. Reports."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ymgme.2019.07.009","article-title":"Perspectives on urea cycle disorder management: results of a clinician survey","volume":"128","author":"Enns","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100906_bb0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/gim.2014.148","article-title":"Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder","volume":"17","author":"Lee","year":"2015","journal-title":"Genet. Med."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:53:25Z","timestamp":1762001605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426922000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":26,"alternative-id":["S2214426922000660"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100906","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable disease manifestations and metabolic management within a single family affected by ornithine transcarbamylase deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100906"}}